Showing results (321-330 of 349) with videos related to
Sort By:
Pageof 35
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal CancerFan Li, Yan Xu, Bovey Liu, et al.Journal of the National Cancer Institute|March 19, 2013
Opportunities and challenges in the era of molecularly targeted agents and radiation therapySteven H Lin, Thomas J George, Edgar Ben-Josef, et al.Journal of Gastrointestinal Oncology|January 13, 2023
A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancerJillian R Gunther, Awalpreet S Chadha, Sushovan Guha, et al.Ebiomedicine|October 30, 2016
H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal CancerMasahisa Ohtsuka, Hui Ling, Cristina Ivan, et al.International Journal of Radiation Oncology, Biology, Physics|February 25, 2019
Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam TherapyCheng-En Hsieh, Bhanu Prasad Venkatesulu, Ching-Hsin Lee, et al.Cancer Research|November 9, 2016
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by RadiotherapyXiaohong Wang, Jonathan E Schoenhals, Ailin Li, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic headGauri R Varadhachary, Robert A Wolff, Christopher H Crane, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 13, 2016
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or MortalityJason W Denbo, Morgan L Bruno, Jordan M Cloyd, et al.JCO Precision Oncology|September 11, 2020
Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic CancerEugene J Koay, Matthew H G Katz, Huamin Wang, et al.Molecular Cancer Therapeutics|May 6, 2010
A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivoKuzhuvelil B Harikumar, Ajaikumar B Kunnumakkara, Nobuo Ochi, et al.Pageof 35